Han-Ting Zhang

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Zhu MJ, Shi J, Chen Y, et al. (2020) Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior. Psychopharmacology
Hou X, Rong C, Wang F, et al. (2020) GABAergic System in Stress: Implications of GABAergic Neuron Subpopulations and the Gut-Vagus-Brain Pathway. Neural Plasticity. 2020: 8858415
Wang H, Zhang FF, Xu Y, et al. (2020) The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer's disease: a preclinical study in APP/PS1 transgenic mice. The International Journal of Neuropsychopharmacology
Pei YA, Davies J, Zhang M, et al. (2020) The Role of Synaptic Dysfunction in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Huang Y, Huang W, Huang Y, et al. (2020) Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice. Journal of Alzheimer's Disease : Jad
Hou X, Xu L, Liu X, et al. (2020) Effects of osthole microemulsion by nasal administration on the cholinergic pathway in mice treated with scopolamine The Faseb Journal. 34: 1-1
Cui SY, Yang MX, Zhang YH, et al. (2019) Protection from amyloid β peptide-induced memory, biochemical and morphological deficits by a phosphodiesterase-4D (PDE4D) allosteric inhibitor. The Journal of Pharmacology and Experimental Therapeutics
Gao Y, Yan Y, Fang Q, et al. (2019) The Rho kinase inhibitor fasudil attenuates Aβ-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons. Metabolic Brain Disease
Xu M, Huang Y, Song P, et al. (2019) AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain. Journal of Alzheimer's Disease : Jad
Zhu X, Li W, Li Y, et al. (2019) The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition. Neuropharmacology